Resources

  • References


    Bussel JB; Cheng G; et al. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.
    N Engl J Med. 2007 Nov 29;357(22):2237-2247.


    Immune thrombocytopenia (ITP). EBSCO DynaMed website. Available at:
    https://dynamed.ebscohost.com/about/about-us. Updated March 28, 2013. Accessed July 11, 2013.


    George JN, Woolf SH, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for The American Society of Hematology. Available at:
    http://www.ouhsc.edu/platelets/itp/ITP%20Publications/pub2%5F1.pdf. Accessed July 11, 2013.


    Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura.
    Lancet. 1997;349:1531-1536.


    Newland A, Caulier MT, et al. An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura.
    Br J Haematol. 2006 Nov;135(4):547-553.


    What is immune thrombocytopenia? National Heart Lung and Blood Institute website. Available at:
    http://www.nhlbi.nih.gov/health/health-topics/topics/itp/. Updated March 14, 2012. Accessed July 11, 2013.

  • Resources

    American Academy of Family Physicians

    http://www.familydoctor.org

    National Heart, Lung, and Blood Institute

    http://www.nhlbi.nih.gov

  • Canadian Resources

    Canadian Medical Association Journal

    http://www.cmaj.ca